Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preliminary classification criteria for the cryoglobulinaemic vasculitis.
De Vita S, Soldano F, Isola M, Monti G, Gabrielli A, Tzioufas A, Ferri C, Ferraccioli GF, Quartuccio L, Corazza L, De Marchi G, Ramos Casals M, Voulgarelis M, Lenzi M, Saccardo F, Fraticelli P, Mascia MT, Sansonno D, Cacoub P, Tomsic M, Tavoni A, Pietrogrande M, Zignego AL, Scarpato S, Mazzaro C, Pioltelli P, Steinfeld S, Lamprecht P, Bombardieri S, Galli M. De Vita S, et al. Among authors: tavoni a. Ann Rheum Dis. 2011 Jul;70(7):1183-90. doi: 10.1136/ard.2011.150755. Epub 2011 May 13. Ann Rheum Dis. 2011. PMID: 21571735 Free PMC article.
Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis.
Quartuccio L, Isola M, Corazza L, Maset M, Monti G, Gabrielli A, Tzioufas AG, Ferri C, Ferraccioli G, Ramos-Casals M, Voulgarelis M, Lenzi M, Mascia MT, Sansonno D, Cacoub P, Tomsic M, Tavoni A, Pietrogrande M, Zignego AL, Scarpato S, Pioltelli P, Steinfeld S, Lamprecht P, Galli M, Bombardieri S, De Vita S. Quartuccio L, et al. Among authors: tavoni a. Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S48-52. Epub 2012 May 14. Clin Exp Rheumatol. 2012. PMID: 22410397
Validation of the classification criteria for cryoglobulinaemic vasculitis.
Quartuccio L, Isola M, Corazza L, Ramos-Casals M, Retamozo S, Ragab GM, Zoheir MN, El-Menyawi MA, Salem MN, Sansonno D, Ferraccioli G, Gremese E, Tzioufas A, Voulgarelis M, Vassilopoulos D, Scarpato S, Pipitone N, Salvarani C, Guillevin L, Terrier B, Cacoub P, Filippini D, Saccardo F, Gabrielli A, Fraticelli P, Sebastiani M, Tomsic M, Tavoni A, Mazzaro C, Pioltelli P, Nishimoto N, Scaini P, Zignego AL, Ferri C, Monti G, Pietrogrande M, Bombardieri S, Galli M, De Vita S. Quartuccio L, et al. Among authors: tavoni a. Rheumatology (Oxford). 2014 Dec;53(12):2209-13. doi: 10.1093/rheumatology/keu271. Epub 2014 Jul 3. Rheumatology (Oxford). 2014. PMID: 24994905
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study.
Quartuccio L, Zuliani F, Corazza L, Scaini P, Zani R, Lenzi M, Tavoni A, Sebastiani M, Baldovino S, Urraro T, Saccardo F, Sbreglia C, Mazzaro C, Pioltelli P, Fraticelli P, Filippini D, Gabrielli A, Perrella O, Scarpato S, Roccatello D, Zignego AL, Ferri C, Bombardieri S, Pietrogrande M, Monti G, Galli M, De Vita S. Quartuccio L, et al. Among authors: tavoni a. J Autoimmun. 2015 Sep;63:88-93. doi: 10.1016/j.jaut.2015.07.012. Epub 2015 Aug 5. J Autoimmun. 2015. PMID: 26255249 Free article. Clinical Trial.
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.
De Vita S, Quartuccio L, Isola M, Mazzaro C, Scaini P, Lenzi M, Campanini M, Naclerio C, Tavoni A, Pietrogrande M, Ferri C, Mascia MT, Masolini P, Zabotti A, Maset M, Roccatello D, Zignego AL, Pioltelli P, Gabrielli A, Filippini D, Perrella O, Migliaresi S, Galli M, Bombardieri S, Monti G. De Vita S, et al. Among authors: tavoni a. Arthritis Rheum. 2012 Mar;64(3):843-53. doi: 10.1002/art.34331. Arthritis Rheum. 2012. PMID: 22147661 Free article. Clinical Trial.
Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar).
Vacchi C, Visentini M, Gragnani L, Fraticelli P, Tavoni A, Filippini D, Saccardo F, Lauletta G, Colantuono S, Atzeni F, Pioltelli P, Manfredi A, Casato M, Zignego AL, Monti G, Pietrogrande M, Galli M, Sebastiani M. Vacchi C, et al. Among authors: tavoni a. Intern Emerg Med. 2021 Jan;16(1):149-156. doi: 10.1007/s11739-020-02386-0. Epub 2020 Jun 10. Intern Emerg Med. 2021. PMID: 32524338
[Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes].
Fabris M, Quartuccio L, De Re V, Pozzato G, Mazzaro C, Tavoni A, Ferri C, Salvin S, Lerussi A, Fabro C, Bombardieri S, De Vita S. Fabris M, et al. Among authors: tavoni a. Reumatismo. 2008 Jan-Mar;60(1):28-34. doi: 10.4081/reumatismo.2008.28. Reumatismo. 2008. PMID: 18810851 Free article. Italian.
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients.
Pietrogrande M, De Vita S, Zignego AL, Pioltelli P, Sansonno D, Sollima S, Atzeni F, Saccardo F, Quartuccio L, Bruno S, Bruno R, Campanini M, Candela M, Castelnovo L, Gabrielli A, Gaeta GB, Marson P, Mascia MT, Mazzaro C, Mazzotta F, Meroni P, Montecucco C, Ossi E, Piccinino F, Prati D, Puoti M, Riboldi P, Riva A, Roccatello D, Sagnelli E, Scaini P, Scarpato S, Sinico R, Taliani G, Tavoni A, Bonacci E, Renoldi P, Filippini D, Sarzi-Puttini P, Ferri C, Monti G, Galli M. Pietrogrande M, et al. Among authors: tavoni a. Autoimmun Rev. 2011 Jun;10(8):444-54. doi: 10.1016/j.autrev.2011.01.008. Epub 2011 Feb 15. Autoimmun Rev. 2011. PMID: 21303705 Free article. Review.
135 results